A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib
How COVID-19 has impacted oncology nursing practice and guidelines
ESMO 2020: New developments in the treatment of lung cancer
SABCS 2020: Conference roundup
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial
PRIME II update: Omitting radiation therapy after breast-conserving surgery for older breast cancer patients
Latest data for managing ALK NSCLC patients
Pregnancy outcomes in breast cancer survivors; meta-analysis
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Real world management of multiple myeloma patients
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia
PARP inhibitors in prostate cancer: A promise delivered